CELLARITY
Cellarity's platform digitizes the molecular information in cells to elucidate how they behave in health and disease. Cellarity is using its platform to design medicines targeting the full cellular and molecular complexity of disease, enabling a quantum leap in the success rate and speed of drug discovery.
CELLARITY
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.cellarity.com
Total Employee:
11+
Status:
Active
Total Funding:
173 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Mobile Non Scaleable Content Nginx
Similar Organizations
Apprentice.io
Apprentice.io helps pharmaceutical producers to bring medicine to patients faster by providing one platform to turn molecules into medicine.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Chronicled
Chronicled builds trust and automation in the life science industry, powered by blockchain.
Cyteir Therapeutics
Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
PetDx
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
Current Advisors List
Current Employees Featured
Founder
Investors List
BlackRock
BlackRock investment in Series B - Cellarity
Flagship Pioneering
Flagship Pioneering investment in Series B - Cellarity
The Baupost Group
The Baupost Group investment in Series B - Cellarity
Pictet Private Equity Investors S.A.
Pictet Private Equity Investors S.A. investment in Series B - Cellarity
Flagship Pioneering
Flagship Pioneering investment in Funding Round - Cellarity
Key Employee Changes
Date | New article |
---|---|
2021-07-20 | Cellarity Bolsters Executive Team with Appointment of Top-Ranked Wall Street Analyst David Risinger as Chief Financial Officer |
Official Site Inspections
http://www.cellarity.com Semrush global rank: 1.37 M Semrush visits lastest month: 20.95 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Cellarity"
Cellarity - Crunchbase Company Profile & Funding
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies. Its platform digitizes the molecular information in cells to elucidate how they behave in health and โฆSee details»
About Us - Cellarity
Cellarity was created by Flagship Pioneering and launched in December 2019. We recognized that powerful new biological and computational technologies exist to perturb and quantify โฆSee details»
Cellarity Company Profile | Management and Employees List
Founded in 2017 and headquartered in Cambridge, Massachusetts, Cellarity is a therapeutics company that is discovering and developing medicines by studying and altering cell behaviors. โฆSee details»
Cellarity Company Profile 2024: Valuation, Funding
Who are Cellarityโs investors? Hanwha Impact, Kyowa Kirin, Hercules Capital, Ahren Innovation Capital, and BlackRock are 5 of 9 investors who have invested in Cellarity. Data Transparency. Meet our data hygiene team. Discover how โฆSee details»
Cellarity - Org Chart, Teams, Culture & Jobs - The Org
Cellarity. Track. Join to edit. Track. Join to edit. Founded by Flagship Pioneering, Cellarity is the first company developing medicines through an understanding of cell behaviors. The โฆSee details»
Cellarity, Inc. Company Profile | Cambridge, MA | Competitors ...
Find company research, competitor information, contact details & financial data for Cellarity, Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
Cellarity - Funding, Financials, Valuation & Investors - Crunchbase
Cellarity is a therapeutics company that uses genomic technologies, data science, and AI to develop a new generation of therapies. Search Crunchbase. ... How much funding has this โฆSee details»
Cellarity - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Cellarity . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Cellarity has 5 current employee profiles, โฆSee details»
Life at Cellarity - Cellarity
Our science runs on diversity: at Cellarity, scientists from a wide range of backgrounds (biology, chemistry, computational biology, machine learning, computational chemistry, data generation, software engineering and data โฆSee details»
Cellarity - workinbiotech.com
Cellarity is developing medicines by understanding cell behaviors. Current drug discovery mediated by focusing on single molecular targets has a high clinical failure rate. Through the โฆSee details»
Cellarity Company Profile - Office Locations, Competitors ... - Craft
Cellarity Summary. Company Summary. Overview. Cellularity is a therapeutic company that develops a platform for drug discovery and creation. Its platform utilizes AI models which are โฆSee details»
Cellarity CEO and Key Executive Team | Craft.co
Cellarity's CEO, Director is Fabrice Chouraqui. Other executives include Nick Plugis, Co-Founder and Chief Innovation Officer; Avak Kahvejian, Board Member and 15 others. See the full โฆSee details»
Cellarity Expands Leadership Team to Continue Evolution of a ...
Feb 10, 2022 Cellarityโs mission is to fundamentally transform the way medicines are created through the development of the first full stack digital cell. Founded by Flagship Pioneering in โฆSee details»
Cellarity - Updates, News, Events, Signals & Triggers - Crunchbase
Cellarity may be growing as it has recently announced a partnership with the Chan Zuckerberg Initiative, which is a significant collaboration likely to enhance its machine learning capabilities โฆSee details»
This Startup Just Raised $123 Million To Develop A New Way To
Feb 25, 2021 Cellarity was founded by venture firm Flagship Pioneering in 2017, and over the course of the past several years has developed seven different therapeutic programs, aimed โฆSee details»
Cellarity Announces Close of $121 Million Series C Financing
Cellarity has developed unique capabilities to link biology and chemistry with high dimensional, transcriptomic data to design medicines against the cellular signature of the disease. The โฆSee details»
Cellarity Raises $123 Million in Series B Funding to Pioneer a New ...
Cellarityโs mission is to bring breakthrough medicines to patients by completely redefining the way drugs are discovered. Founded by Flagship Pioneering in 2017, Cellarity is designing โฆSee details»
Cellarity Expands Leadership Team to Continue Evolution of a ...
Feb 10, 2022 Cellarity's transformative approach to drug creation looks beyond an individual molecular target to understand the complex biological network of cellular changes that underlie โฆSee details»
Pipeline - Cellarity
Cellarity is creating โgame-changingโ drugs that are out of reach today. Having proven the concept of our platform across diverse cell types and cell behaviors, we have selected โฆSee details»